Accolate and Urinary tract infection - a phase IV clinical study of FDA data

Summary:

Urinary tract infection is reported as a side effect among people who take Accolate (zafirlukast), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Xolair, and have Osteoporosis.

The phase IV clinical study analyzes which people have Urinary tract infection when taking Accolate. It is created by eHealthMe based on reports of 4,145 people who have side effects when taking Accolate from the FDA, and is updated regularly.

What is Accolate?

Accolate has active ingredients of zafirlukast. It is often used in asthma. eHealthMe is studying from 4,220 Accolate users. Check the latest studies of Accolate.

What is Urinary tract infection?

Urinary tract infection is found to be associated with 3,013 drugs and 3,957 conditions by eHealthMe. Check the latest studies of Urinary tract infection.

On Jul, 13, 2026

4,145 people reported to have side effects when taking Accolate.
Among them, 56 people (1.35%) have Urinary tract infection.

Could Accolate cause Urinary tract infection?

Among these 56 people:

How long have people been on Accolate when they have Urinary tract infection? *

What is the gender of people who have Urinary tract infection when taking Accolate? *

female: 94.55 %
male: 5.45 %

What is the age of people who have Urinary tract infection when taking Accolate? *

What are other drugs people take besides Accolate? *

What are other side effects people have besides Urinary tract infection? *

Dyspnea (difficult or laboured breathing): 27 people, 48.21%
Headache (pain in head): 26 people, 46.43%
Nausea (feeling of having an urge to vomit): 26 people, 46.43%
Fall: 25 people, 44.64%
Cough: 24 people, 42.86%
Back Pain: 24 people, 42.86%
Pain: 23 people, 41.07%
Dizziness: 22 people, 39.29%
Nausea And Vomiting: 22 people, 39.29%
Muscle Aches (muscle pain): 21 people, 37.50%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 10 people, 17.86%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 6 people, 10.71%
Diabetes: 5 people, 8.93%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 7.14%
Skin Ulcer: 3 people, 5.36%
Hypersensitivity: 3 people, 5.36%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 5.36%
Type 2 Diabetes: 2 people, 3.57%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 3.57%
Birth Control: 2 people, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Accolate and have Urinary tract infection?

- Check whether Urinary tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Accolate:

Accolate (4,220 reports)

Browse all side effects of Accolate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary tract infection:

Urinary tract infection (3,013 drugs)

Browse all the conditions that are associated with Urinary tract infection:

Urinary tract infection (3,957 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zafirlukast (the active ingredients of Accolate) and Accolate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.